During the past decade, Onkologisch-Hämatologische Schwerpunktpraxis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologisch-Hämatologische Schwerpunktpraxis" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Onkologisch-Hämatologische Schwerpunktpraxis" are "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Onkologisch-Hämatologische Schwerpunktpraxis" in a lesser frequency.

Most popular intervention types in "Onkologisch-Hämatologische Schwerpunktpraxis" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "T-DM1" (1 trials) and "eHealth system support for symptom management via CANKADO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkologisch-Hämatologische Schwerpunktpraxis" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Onkologisch-Hämatologische Schwerpunktpraxis". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Onkologisch-Hämatologische Schwerpunktpraxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologisch-Hämatologische Schwerpunktpraxis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Onkologisch-Hämatologische Schwerpunktpraxis has several departments that took part in Clinical trials: "Hämato-Onkologie im Medicum/Home" - 2 trials